Doug Mahoney re-focuses experience with viruses on urgent exploration

From cancer to COVID: Med school researchers may hold key to vaccine creation

Posted on

Dr. Doug Mahoney, PhD, has spent a lifetime working with viruses. Normally, his studies at the Cumming School of Medicine involve the cancer-fighting variety — viruses that can replicate and attack tumour cells while stimulating the body’s own immune system.

His hope now, during the pandemic, is that one of these cancer treatments that has already been developed and safely tested in people can be modified and repurposed as a vaccine for COVID-19…..

https://ucalgary.ca/news/cancer-covid-med-school-researchers-may-hold-key-vaccine-creation?mkt_tok=eyJpIjoiWkRFMFlUbGtabUUyT1dNeSIsInQiOiJ1MlQyNDVCUGZcL05ESjZrYWtHcmtiMGNxUGNkcVJIM1VZUFpaUDNta3l4RTh2SkhwTlludUNkMHVheVdLbnpEK1VsSnA1UzRobWFtdnlBK2lKTElxRlBaZDEwVk5VMWd5YWFYMkdRYWNMRTR6ZHFFa0d3ZTY1bTBNVVdGSWtcL3NRIn0%3D

Read More Impact Stories

Posted on
McGill-developed device offers 100 per cent accuracy in as little as 10 minutes, and can be configured to detect a [...]
Posted on
This content is available in French only.
Posted on
The University of Toronto and Moderna, Inc. known for its mRNA-based COVID-19 vaccine plan to work together to develop new [...]